[Event Report] Making the ‘Silent Pandemic’ of AMR Heard: What Countries Leading the Charge Against AMR are Doing to Ensure their Populations are Protected (April 28, 2022)
date : 11/28/2022
Tags: AMR
*The report of this symposium has been published. (November 28, 2022)
On April 28, 2022, AMR Alliance Japan (Secretariat: Health and Global Policy Institute) held a symposium gathering experts from Japan and other countries that are leading the way in the fight against AMR. Participants from Japan, Germany, the United Kingdom, and the United States discussed each country’s AMR response, and possibilities for future collaborations in this space.
This symposium shared international best practices for stronger policy responses against AMR as well as trends of policy discussions on this issue. Moving forward, AMR Alliance Japan and HGPI will continue to work to make the ‘silent pandemic’ of AMR heard.
[Overview]
- Date and time: April 28, 2022; 18:00-19:30, JST
- Format: Online using the Zoom conferencing system
- Host: AMR Alliance Japan / Health and Global Policy Institute (HGPI)
- Languages: English and Japanese (simultaneous interpretation will be provided)
- Participation fee: Free
[Program]
18:00-18:05 Welcome and Introduction
Matt McEnany (Senior Manager, Health and Global Policy Institute / AMR Alliance Japan)
18:05-18:10 Opening Remarks
Yasuhisa Shiozaki (Former Member, House of Representatives / Member, WHO Global Leaders Group on Antimicrobial Resistance)
18:10-18:20 – Looking Back on the UK’s G7 Presidency – Future Plans for AMR Policy
Sally Davies (UK Special Envoy on Antimicrobial Resistance / Member, WHO Global Leaders Group on Antimicrobial Resistance)
18:20-18:30 – AMR in Germany’s G7 Presidency
Dagmar Reitenbach (Head of Division Global Health, Federal Ministry of Health (BMG), Germany)
18:30-18:40 – AMR Policy Priorities in the United States and Across Europe
Kevin Outterson (Executive Director, CARB-X)
18:40-18:50 – Japanese Leadership on AMR Countermeasures
Norio Ohmagari (Director, Department of Infectious Diseases, National Center for Global Health and Medicine / Director, AMR Clinical Reference Center, National Center for Global Health and Medicine)
18:50 – 19:30 Panel Discussion / Q&A
Panelists
- Sally Davies (UK Special Envoy on Antimicrobial Resistance / Member, WHO Global Leaders Group on Antimicrobial Resistance)
- Dagmar Reitenbach (Head of Division Global Health, Federal Ministry of Health (BMG), Germany)
- Kevin Outterson (Executive Director, CARB-X)
- Norio Ohmagari (Director, Department of Infectious Diseases, National Center for Global Health and Medicine / Director, AMR Clinical Reference Center, National Center for Global Health and Medicine)
- Eiji Hinoshita (Assistant Minister for Global Health and Welfare, Ministry of Health, Labour and Welfare)
Moderator
Matt McEnany (Senior Manager, Health and Global Policy Institute / AMR Alliance Japan)
Top Research & Recommendations Posts
- [Research Report] Energy Conservation and Greenhouse Gas Emissions Reduction in Healthcare Facilities: Case Studies from New Construction and Facility Renewal (March 16, 2026)
- [Research Report] Perceptions, Knowledge, Actions and Perspectives of Healthcare Organizations in Japan in Relation to Climate Change and Health: A Cross-Sectional Study (November 13, 2025)
- [Event Report and Discussion Points] AI Diagnostic Support Project Expert Meeting: “The Roles of Industry, Government, Academia, and Civil Society in the Era of AI-Assisted Diagnosis” (May 25, 2026)
- [Public Comment Submission] “The 7th Science, Technology and Innovation Basic Plan” (Draft) (February 19, 2026)
- [Policy Recommendations] Policy Recommendations in the Field of Blood Disorders “Building a Healthcare Ecosystem Centered on Patients and Those Affected” (April 13, 2026)
- [Policy Recommendations] Reshaping Japan’s Immunization Policy for Life Course Coverage and Vaccine Equity: Challenges and Prospects for an Era of Prevention and Health Promotion (April 25, 2025)
- [Policy Recommendations] Developing a National Health and Climate Strategy for Japan (June 26, 2024)
- [Research Report] The 2026 Public Opinion Survey on Healthcare in Japan (February 13, 2026)
- [Research Report] The 2025 Public Opinion Survey on Healthcare in Japan (March 17, 2025)
- [Policy Recommendations] Dementia Project “The Future of Dementia Policy Surrounding Families and Others Who Care for People with Dementia” (April 27, 2026)
Featured Posts
-
2026-05-13
[Registration Open] HGPI Salon 2025-2026 Looking Ahead to the Future of Japan’s Social Security System “Session 5: The Value of Healthcare in Society – Perspectives from the Reiwa Era” (June 29, 2026)
-
2026-06-04
[Registration Open] (Webinar) The 3rd J-PEP Seminar “Social Participation of People with Intractable Diseases and the Potential of a New Way of Working — ‘RD Workers’ — Lessons from Policy Advocacy Practice” (July 22, 2026)
-
2026-06-15
[Registration Open] (Hybrid Format) Multidisciplinary Symposium for Cardiology, Nephrology, and Metabolic Medicine “Future Actions for Making Full Use of the Health Checkup System: Connecting Checkups to Treatment From the Perspective of Data Linkage” (July 6, 2026)



